also showed that plasma BC200 RNA levels were markedly elevated in invasive breast cancer patients compared to healthy subjects (94, 174), indicating that BC200 is a noninvasive molecular marker for invasive breast cancer detection. This evidence concerns the gene BCYRN1 and invasive breast carcinoma.